Regeneron said it will continue uninterrupted service of 23andMe’s consumer genome services after its purchase closes as ...

Two groundbreaking biotechnology advances are fundamentally altering human health and food production in 2025, moving from ...

In its announcement of the acquisition, Regeron claimed it would ensure that customers’ personal data including genetic and ...

The top bidder in the DNA testing firm's bankruptcy auction, Regeneron vows to prioritize the privacy, security, and ethical use of customer data.

Biotechnology has emerged as a driving force in transforming healthcare. Over the past few decades, the integration of biology with advanced technology has led to significant breakthroughs. These ...

Bankrupt DNA testing company 23andMe was purchased Monday by biotechnology company Regeneron for $256 million. Both companies ...

Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer ...

A biotech company has announced plans to acquire 23andMe after the genetic testing company filed for Chapter 11 bankruptcy.

In today's episode podcast host Kerry Lonergan catches up with US animal genetics expert and award-winning ag communicator ...